BRIEF published on 05/22/2026 at 14:01, 5 months 13 days ago Déclaration de Apex Fundrock Limited (formulaire 8.3) concernant Advanced Medical Sol Group PLC Gestion D'actifs Formulaire 8.3 Informations Sur Les Valeurs Mobilières Groupe De Solutions Médicales Avancées Poste À Pourvoir
BRIEF published on 05/22/2026 at 14:01, 5 months 13 days ago Apex Fundrock Limited's Form 8.3 Disclosure on Advanced Medical Sol Group PLC Asset Management Form 8.3 Securities Disclosure Opening Position Advanced Medical Sol Group
PRESS RELEASE published on 05/22/2026 at 13:56, 5 months 13 days ago Form 8.3 - Advanced Medical Sol Group PLC - Opening Position Disclosure Chelverton Asset Management discloses a 1.36% interest in Advanced Medical Sol Group PLC. No other party disclosures made Interests Chelverton Asset Management Disclosures 1.36% Advanced Medical Sol Group PLC
BRIEF published on 05/20/2026 at 15:37, 5 months 15 days ago Disclosure of Investment Positions by Chelverton Asset Management in Checkit PLC Form 8.3 Takeover Code Securities Disclosure Chelverton Asset Management Checkit PLC
BRIEF published on 05/20/2026 at 15:37, 5 months 15 days ago Divulgation des positions d'investissement de Chelverton Asset Management dans Checkit PLC Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Checkit PLC Gestion D'actifs De Chelsea
PRESS RELEASE published on 05/20/2026 at 15:32, 5 months 15 days ago Form 8.3 - Checkit PLC Chelverton Asset Management discloses a 2.71% interest in Checkit PLC's Ordinary shares. No other parties involved in the offer Ordinary Shares Open Position Disclosure Chelverton Asset Management Checkit PLC 2.71%
BRIEF published on 05/15/2026 at 15:19, 5 months 20 days ago Disclosure Update on Gamma Communications PLC by Chelverton Asset Management Form 8.3 Securities Disclosure Share Sale Chelverton Asset Management Gamma Communications PLC
BRIEF published on 05/15/2026 at 15:19, 5 months 20 days ago Mise à jour des informations sur Gamma Communications PLC par Chelverton Asset Management Formulaire 8.3 Vente D'actions Information Sur Les Valeurs Mobilières Gestion D'actifs De Chelsea Gamma Communications PLC
PRESS RELEASE published on 05/15/2026 at 15:14, 5 months 20 days ago Form 8.3 - Gamma Communications PLC Chelverton Asset Management discloses a 0.99% interest in Gamma Communications PLC. The dealing was undertaken on 14th May 2026 Dealing Disclosure Chelverton Asset Management Gamma Communications PLC 0.99% 14th May 2026
BRIEF published on 05/15/2026 at 14:54, 5 months 20 days ago Chelverton Asset Management Discloses Stake in Advanced Medical Solutions Form 8.3 Takeover Code Shareholding Disclosure Chelverton Asset Management Advanced Medical Solutions
Published on 11/04/2026 at 23:10, 4 hours 58 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 8 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 53 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours 3 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:55, 13 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 58 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 6 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 27 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 43 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:00, 10 hours 8 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 8 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 10 hours 24 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
